Dissecting the complex regulation of Mad4 in glioblastoma multiforme cells

Cancer Biology and Therapy

Volumn 13, Issue 13, 2012, Pages 1339-1348

  Yang, Wensheng ^a   Yang, Xiaolu ^a   David, Gregory ^b   Dorsey, Jay F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C IAP1; C Myc; Glioblastoma multiforme cell lines; Mad4; Sin3A; Sin3B

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CELL PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MAD4 PROTEIN; MYC PROTEIN; PROTEIN MAD1; SIN3B PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SIN3A; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84868361906     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.21814     Document Type: Article

References (28)

1. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 2003; 100:8164-9; PMID:12808131; http://dx.doi.org/10.1073/pnas. 1332764100.
2. Perna D, Fagà G, Verrecchia A, Gorski MM, Barozzi I, Narang V, et al. Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts. Oncogene 2012; 31:1695-709; http://dx.doi.org/10.1038/onc.2011.359; PMID:21860422.
3. Lüscher B, Larsson LG. The basic region/helix-loophelix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 1999; 18:2955-66; PMID:10378692; http://dx.doi.org/10.1038/sj.onc.1202750.
4. Hurlin PJ, Huang J. The MAX-interacting transcription factor network. Semin Cancer Biol 2006; 16:265-74; PMID:16908182; http://dx.doi.org/10.1016/j. semcancer.2006.07.009.
5. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6:635-45; PMID:16064138; http://dx.doi.org/10.1038/nrm1703.
6. Marcotte R, Qian JF, Chen J, Wang E. hMad4, c-Myc endogenous inhibitor, induces a replicative senescencelike state when overexpressed in human fibroblasts. J Cell Biochem 2003; 89:576-88; PMID:12761891; http://dx.doi.org/ 10.1002/jcb.10517.
7. David G, Grandinetti KB, Finnerty PM, Simpson N, Chu GC, Depinho RA. Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci U S A 2008; 105:4168-72; PMID:18332431; http://dx.doi.org/10.1073/pnas.0710285105.
8. Grandinetti KB, Jelinic P, DiMauro T, Pellegrino J, Fernández Rodríguez R, Finnerty PM, et al. Sin3B expression is required for cellular senescence and is up-regulated upon oncogenic stress. Cancer Res 2009; 69:6430-7; PMID:19654306; http://dx.doi.org/10.1158/0008-5472.CAN-09-0537.
9. Jelinic P, Pellegrino J, David G. A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II progression within transcribed loci. Mol Cell Biol 2011; 31:54-62; PMID:21041482; http://dx.doi.org/10.1128/MCB.00840-10.
10. Dannenberg JH, David G, Zhong S, van der Torre J, Wong WH, Depinho RA. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 2005; 19:1581-95; PMID:15998811; http://dx.doi.org/10.1101/gad.1286905.
11. Xu L, Zhu J, Hu X, Zhu H, Kim HT, LaBaer J, et al. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol Cell 2007; 28:914-22; PMID:18082613; http://dx.doi.org/10.1016/j.molcel.2007.10.027.
12. Srinivasula SM, Ashwell JD. IAPs: what's in a name? Mol Cell 2008; 30:123-35; PMID:18439892; http://dx.doi.org/10.1016/j.molcel.2008.03.008.
13. Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 2010; 10:561-74; PMID:20651737; http://dx.doi.org/10.1038/nrc2889.
14. Li X, Yang Y, Ashwell JD. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002; 416:345-7; PMID:11907583; http://dx.doi.org/10.1038/416345a.
15. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T, et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 2005; 25:3348-56; PMID:15798218; http://dx.doi.org/10.1128/MCB.25.8.3348-3356.2005.
16. Zhao Y, Conze DB, Hanover JA, Ashwell JD. Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J Biol Chem 2007; 282:7777-82; PMID:17220297; http://dx.doi.org/10.1074/jbc.M609146200.
17. Csomos RA, Brady GF, Duckett CS. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J Biol Chem 2009; 284:20531-9; PMID:19506082; http://dx.doi.org/10.1074/jbc.M109. 029983.
18. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al.; Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 2010; 17:98-110; PMID:20129251; http://dx.doi.org/10.1016/j.ccr.2009.12.020.
19. Marcotte R, Chen JM, Huard S, Wang E. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts. J Cell Biochem 2005; 96:1071-85; PMID:16167342; http://dx.doi.org/10.1002/jcb.20503.
20. Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell 1999; 3:169-79; PMID:10078200; http://dx.doi.org/10.1016/ S1097-2765(00)80308-1.
21. Kong Q, Zeng W, Wu J, Hu W, Li C, Mao B. RNF220, an E3 ubiquitin ligase that targets Sin3B for ubiquitination. Biochem Biophys Res Commun 2010; 393:708-13; PMID:20170641; http://dx.doi.org/10.1016/j.bbrc.2010.02.066.
22. Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O, et al. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 2007; 9:331-8; PMID:17293853; http://dx.doi.org/10.1038/ncb1545.
23. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, et al. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012; 12:22; PMID:22251860; http://dx.doi.org/10.1186/1471-2407-12-22.
24. Wang Y, Engels IH, Knee DA, Nasoff M, Deveraux QL, Quon KC. Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 2004; 5:501-12; PMID:15144957; http://dx.doi.org/10.1016/S1535-6108(04) 00113-8.
25. Nieminen AI, Partanen JI, Hau A, Klefstrom J. c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis. EMBO J 2007; 26:1055-67; PMID:17268552; http://dx.doi.org/10.1038/sj.emboj.7601551.
26. Larsson LG, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010; 316:1429-37; PMID:20382143; http://dx.doi.org/10.1016/j.yexcr.2010.03.025.
27. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997; 8:1039-48; PMID:9342182.
28. Mei Y, Hahn AA, Hu S, Yang X. The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2. J Biol Chem 2011; 286:35380-7; PMID:21849505;http://dx.doi.org/10.1074/jbc.M111.282020.